➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Moodys
Baxter
Boehringer Ingelheim

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PF-06882961

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PF-06882961?

PF-06882961 is an investigational drug.

There have been 6 clinical trials for PF-06882961. The most recent clinical trial was a Phase 1 trial, which was initiated on July 15th 2019.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There is one US patent protecting this investigational drug and twenty-four international patents.

Recent Clinical Trials for PF-06882961
TitleSponsorPhase
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes MellitusPfizerPhase 1
Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961PfizerPhase 1
A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes MellitusPfizerPhase 2

See all PF-06882961 clinical trials

Clinical Trial Summary for PF-06882961

Top disease conditions for PF-06882961
Top clinical trial sponsors for PF-06882961

See all PF-06882961 clinical trials

International Patents for PF-06882961

Drugname Country Document Number Estimated Expiration Related US Patent
PF-06882961 Argentina 110387 2036-12-16   Start Trial
PF-06882961 Australia 2017374860 2036-12-16   Start Trial
PF-06882961 Brazil 112019012211 2036-12-16   Start Trial
PF-06882961 Canada 2988721 2036-12-16   Start Trial
PF-06882961 Chile 2019001651 2036-12-16   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Moodys
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.